UPDATED Apr 30, 2024
Discover Swiss Growth Stocks that are on the SMI. Sorted by forecasted growth, these stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
ASWN | CHF1.51 | -1.3% | -22.2% | CHF21.8m | n/a | PE14.2x | n/a | n/a | Media | ||
NREN | CHF34.00 | -1.4% | -14.4% | CHF262.2m | n/a | PS8.8x | n/a | 3.7% | Real Estate Management and Development | ||
LLBN | CHF70.30 | 1.0% | 11.6% | CHF2.2b | CHF80.00 | PB1x | S1.5% | 3.8% | Banks | ||
AEVS | CHF15.00 | 4.2% | -16.7% | CHF1.3b | n/a | PS1.5x | n/a | 0% | Healthcare | ||
FREN | CHF16.60 | 1.2% | 0.6% | CHF499.0m | n/a | PE60.1x | S7.2% | 3.3% | Real Estate Management and Development | ||
SAHN | CHF496.00 | 1.2% | 73.4% | CHF312.9m | n/a | PE15.6x | n/a | 1.8% | Tech | ||
AHAN | CHF0.38 | 0% | -94.8% | CHF364.5k | n/a | PB0.04x | n/a | 1,102.6% | Real Estate | ||
QCAP | CHF29.00 | 0% | n/a | CHF23.1m | n/a | PS26.5x | n/a | n/a | Diversified Financials | ||
EVE | CHF1.01 | 7.2% | -94.7% | CHF7.3m | n/a | PS1.8x | n/a | n/a | Materials | ||
SDPN | CHF0.01 | 0% | n/a | CHF2.1m | n/a | PE-15.8x | n/a | n/a | Software | ||
ADMI | CHF10.00 | 11.1% | n/a | CHF22.2m | n/a | PS2.5x | n/a | 0% | Real Estate Management and Development | ||
HLEE | CHF8.80 | -8.3% | -46.3% | CHF114.0m | n/a | PB1.4x | n/a | n/a | Media | ||
THAG | CHF0.005 | 0% | -55.4% | CHF2.3m | n/a | n/a | n/a | n/a | Media | ||
CIE | CHF1.31 | -3.7% | -41.0% | CHF851.5k | n/a | PE-4.4x | n/a | n/a | Real Estate Management and Development | ||
PEDU | CHF54.50 | 0% | -33.5% | CHF7.3m | n/a | PB0.6x | n/a | 3.7% | Capital Goods | ||
TKBP | CHF127.00 | -1.2% | 7.6% | CHF2.5b | n/a | PB0.9x | S1.0% | 2.6% | Banks | ||
BCGE | CHF298.00 | 0.7% | 44.7% | CHF2.1b | n/a | PB1x | S2.3% | 1.6% | Banks | ||
CURN | CHF16.25 | n/a | n/a | CHF71.3m | n/a | n/a | n/a | n/a | Pharmaceuticals & Biotech | ||
XLS | CHF32.00 | -8.3% | 4.2% | CHF182.5m | CHF68.00 | PE12.3x | n/a | n/a | Pharmaceuticals & Biotech | ||
EPIC | CHF73.80 | 0.8% | 15.7% | CHF762.4m | n/a | PE43.2x | S0.6% | 4.2% | Real Estate Management and Development | ||
SEGN | CHF3.85 | 0% | n/a | CHF171.2m | n/a | PE13.2x | n/a | 4.9% | Real Estate Management and Development | ||
BCJ | CHF63.00 | 3.3% | 15.6% | CHF188.6m | n/a | PB0.6x | n/a | 3.6% | Banks | ||
VZN | CHF106.20 | 0.8% | 29.5% | CHF4.2b | n/a | PE22.4x | S5.8% | 2.1% | Diversified Financials | ||
NBEN | CHF7.35 | -1.3% | -17.4% | CHF67.1m | n/a | PS29.6x | n/a | 4.4% | Diversified Financials |